Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection

BACKGROUND: Antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 acute infection has increased. Currently, most of the evidence relates to patients in intensive care units; however, there is little information on patients admitted to hospital wards and there is no consensus protocol o...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiros Ambel, Helena, Crespo-Robledo, Paloma, Arribalzaga Juaristi, Karmele, Plo-Seco, Isabel, Martínez Simón, Jose Javier, Pérez Fernández, Elia, Perez Encinas, Monserrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523220/
https://www.ncbi.nlm.nih.gov/pubmed/34649964
http://dx.doi.org/10.1136/ejhpharm-2021-002877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523220/
https://www.ncbi.nlm.nih.gov/pubmed/34649964
http://dx.doi.org/10.1136/ejhpharm-2021-002877

Ejemplares similares